𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Towards a need to a “biological Sokal risk” in the era of tyrosine kinase inhibitors in choosing front-line therapy in chronic myeloid leukemia

✍ Scribed by Fabio Stagno; Paolo Vigneri; Francesco Di Raimondo


Book ID
113773711
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
100 KB
Volume
36
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES